Dentsply Sirona
Makes professional dental equipment, workflow software, consumables and continence-care devices.
Something off on this page? Send us feedback.
Profile
Sells professional-dental equipment, workflow software and recurring consumables alongside implants, orthodontic appliances and continence-care devices. Revenue pairs connected capital equipment with recurring product sales and depends materially on distributors for dental consumable and equipment distribution.
Combines Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The range runs from imaging, scanners, treatment centers, CEREC CAD/CAM and workflow software to restorative and endodontic consumables, SureSmile aligners, implants and continence-care products. Sales reach dental professionals, laboratories, medical providers and patients in roughly 140 countries, with Europe the largest region and the United States its next-largest market.
Generates most revenue from manufactured devices, instruments and consumables, supplemented by digital-workflow software and services. Much of dental consumable and equipment volume moves through third-party distributors, while implants, endodontics and orthodontics also reach practitioners and labs directly. Demand for financed equipment and elective procedures, global device regulation and data requirements, a multi-year ERP rollout, and a manufacturing footprint spanning Europe and the United States are structural dependencies.
Company facts
Categories
Key statistics
Year to date −1.3% · Average volume (30d) 4.5M
Analysts
Ratings
Target range
Latest analyst notes
| Date | Firm | Action | Prior rating | Rating | Prior target | Target |
|---|---|---|---|---|---|---|
| Aug 24, 2026 | Barclays | Reiterate | Underweight | $9 | $11 | |
| Aug 10, 2026 | Barrington | Target | $18 | $15 | ||
| Aug 7, 2026 | BMO Capital | Reiterate | Market Perform | $12 | $13 | |
| Jul 29, 2026 | Piper Sandler | Reiterate | Neutral | $32 | $14 | |
| Jul 8, 2026 | BMO Capital | Initiate | Market Perform | $12 |
Earnings
EPS
Revenue
History
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Next session |
|---|---|---|---|---|---|---|---|
| Aug 6, 2026Q2 FY26 | $0.35 | $0.52 | +49.4% | $889.9M | $898.0M | +0.9% | −7.97% |
| May 5, 2026Q1 FY26 | $0.28 | $0.27 | −3.6% | $841.8M | $880.0M | +4.5% | −2.02% |
| Feb 26, 2026Q4 FY25 | $0.28 | $0.27 | −3.6% | $926.2M | $961.0M | +3.8% | +15.50% |
| Nov 6, 2025Q3 FY25 | $0.45 | $0.37 | −17.8% | $927.1M | $904.0M | −2.5% | +1.45% |
Financial highlights
| 12 quarters | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | |
|---|---|---|---|---|---|---|---|
| Revenue | $879.0M | $936.0M | $904.0M | $961.0M | $880.0M | $898.0M | |
| Gross profit | $466.0M | $490.0M | $441.0M | $443.0M | $427.0M | $493.0M | |
| Operating income | $63.0M | −$128.0M | $46.0M | $268.0M | $30.0M | $82.0M | |
| Net income | $20.0M | −$45.0M | −$427.0M | −$146.0M | −$10.0M | $37.0M | |
| Diluted EPS | $0.10 | −$0.23 | −$2.14 | −$0.73 | −$0.05 | $0.18 | |
| Gross margin | 53.0% | 52.4% | 48.8% | 46.1% | 48.5% | 54.9% | |
| Operating margin | 7.2% | -13.7% | 5.1% | 27.9% | 3.4% | 9.1% |
Fiscal years (4-quarter sums)FY21 $4.22B · FY22 $3.92B · FY23 $3.97B · FY24 $3.79B · FY25 $3.68B
Revenue by geography · Q4 FY25
Balance sheet, Jun 30, 2026Cash & short-term investments $239.0M · Total debt $2.31B · Total assets $5.20B · Shareholders' equity $1.35B
Dividends
Raised for 30 straight years — most recently to $0.16 from $0.14 in Mar 2024.
History
| Ex-date | Record | Paid | Amount | Note |
|---|---|---|---|---|
| Dec 26, 2025 | Dec 26 | Jan 9 | $0.16 | |
| Sep 26, 2025 | Sep 26 | Oct 10 | $0.16 | |
| Jun 27, 2025 | Jun 27 | Jul 11 | $0.16 | |
| Mar 28, 2025 | Mar 28 | Apr 11 | $0.16 | |
| Dec 27, 2024 | Dec 27 | Jan 10 | $0.16 | |
| Sep 27, 2024 | Sep 27 | Oct 11 | $0.16 | |
| Jun 28, 2024 | Jun 28 | Jul 12 | $0.16 | |
| Mar 27, 2024 | Mar 29 | Apr 12 | $0.16 | raised from $0.14 |
Ownership
A 13F quarter can total more than the shares outstanding — sub-advisers file the same block twice, and a filer's own share count can be a quarter stale. No split is drawn from it.
Shares outstanding 200.33M · Float 199.22M · 99.5% free float
Top shareholders13F · 13D/G · Form 4
| Holder | Shares | % outstanding | Form | Filed |
|---|---|---|---|---|
| BlackRock, Inc. | 26.71M | 13.33% | 13F | Aug 7, 2026 |
| First Eagle Investment Management, LLC | 14.15M | 6.98% | 13D/G | Nov 12, 2024 |
| Fuller & Thaler Asset Management, Inc. | 12.70M | 6.34% | 13F | Aug 12, 2026 |
| Vanguard Portfolio Management LLC | 11.78M | 5.88% | 13F | Aug 13, 2026 |
| AQR Capital Management LLC | 10.46M | 5.22% | 13F | Aug 14, 2026 |
Insider tradesForm 4
| Date | Insider | Role | Shares | Avg price |
|---|---|---|---|---|
| Jun 12, 2026 | Jonathan Jay Mazelsky | director | +10,000 | $10.14 |
| Jun 15, 2026 | Clyde Hosein | director | +6,500 | $9.99 |
| Jun 11, 2026 | Michael J. Barber | director | +15,175 | $9.89 |
| Jun 11, 2026 | Betsy D. Holden | director | +10,086 | $9.88 |
| Jun 15, 2026 | Brian T. Gladden | director | +9,985 | $10.02 |
Peers
- Envista
Dental portfolio overlaps imaging, consumables, implants, and orthodontics.
- Align Technology
Clear aligners and digital scanners target orthodontic and GP dentists.
- Solventum
Dental materials and orthodontics overlap core consumables.
CompareAfter-hours close
| Company | Price | Change | |||||
|---|---|---|---|---|---|---|---|
| Dentsply Sirona | $11.13 | +0.09% | $2.23B | — | 7.5 | 0.6 | −4.1% |
| Envista | $27.00 | −0.52% | $4.41B | 46.8 | 17.2 | 1.5 | +7.1% |
| Align Technology | $157.58 | +0.01% | $11.29B | 27.4 | 13.3 | 2.7 | +4.3% |
| Solventum | $90.50 | −0.68% | $15.78B | 11.1 | 13.5 | 1.9 | +2.2% |
| Median | 27.4 | 13.5 | 1.9 | +4.3% |